Inovio Pharmaceuticals Inc. shares tumbled 22% Tuesday, a day after the company reported a broader-than-expected second-quarter loss and offered a limited update on its COVID-19 vaccine candidate that is currently in clinical trials. The stock INO, -22.88% is still up 343% year-on-year after winning early in the coronavirus pandemic in …
Read More »
Inovio Pharmaceuticals Inc. shares tumbled 22% Tuesday, a day after the company reported a broader-than-expected second-quarter loss and offered a limited update on its COVID-19 vaccine candidate that is currently in clinical trials. The front INO is still up 343% year-on-year after winning early in the coronavirus pandemic in hopes …
Read More »
In this March 16, 2020 file photo, a subject receives an injection in the first-stage safety study clinical trial of a possible Moderna vaccine for COVID-19, the disease caused by the new coronavirus, in the Kaiser Permanente Washington Health Research Institute in Seattle. Ted S. Warren | AP A Goldman …
Read More »
Tesla Motors CEO Elon Musk reacts after the company’s initial public offering on the NASDAQ market in New York on June 29, 2010 Brendan McDermid | Reuters Check out the companies that make headlines after the bell: Tesla: Auto maker shares rose 1% in extended trade. Tesla shares were up …
Read More »
Shares of Inovio Pharmaceuticals Inc. rebounded to a 20-year high in high volumes on Friday, erasing a previous sharp loss, after a longtime bull downgraded the Pennsylvania-based biotech company, and later that the company disclosed some terms of the funding agreement with the US Department of Defense announced earlier this …
Read More »